Meridian Bioscience (VIVO) Reports In-Line Q4 EPS
Get Alerts VIVO Hot Sheet
Price: $33.97 --0%
Revenue Growth %: -100.0%
Financial Fact:
Selling and marketing: 8.13M
Today's EPS Names:
SHIM, KOD, HEWA, More
Revenue Growth %: -100.0%
Financial Fact:
Selling and marketing: 8.13M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $47 million versus the consensus estimate of $47.7 million.Meridian Bioscience reaffirmed FY2017 guidance.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Tops Q4 EPS by 18c, provides guidance
- Schwazze (SHWZ) Misses Q4 EPS by 30c
- Koil Energy Solutions, Inc. (KLNG) Reports Q4 Loss of $0.07
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!